Value through Innovation27 July 2016

Clinical Study Results

  • Telmisartan + Lacidipine - Healthy
    Clinical Study Number 1173.1
    Study Indication Healthy
    Product Telmisartan + Lacidipine
    Generic Name Telmisartan + Lacidipine
    Lab Code
    Clinical Phase I
    Study Title

    Tolerability and pharmacokinetics of 80 mg telmisartan in combination with 2, 4 or 6 mg lacidipine. An open, single rising dose group comparison trial - placebo randomised double blind in each dose group - in male healthy subjects.

    Study Document Trial synopsis 1173.1_CO english
  • Telmisartan + Lacidipine - Healthy
    Clinical Study Number 1173.2
    Study Indication Healthy
    Product Telmisartan + Lacidipine
    Generic Name Telmisartan + Lacidipine
    Lab Code
    Clinical Phase I
    Study Title

    Tolerability and pharmacokinetics of 80 mg telmisartan and 6 mg lacidipine alone and in combination after 7 days treatment. An open randomised three-way cross-over trial in female and male healthy subjects.

    Study Document Trial synopsis 1173.2_CO english
  • Telmisartan + Lacidipine - Healthy
    Clinical Study Number 1173.6
    Study Indication Healthy
    Product Telmisartan + Lacidipine
    Generic Name Telmisartan + Lacidipine
    Lab Code
    Clinical Phase I
    Study Title

    Bioavailability of Lacidipine 4 mg and Telmisartan 40 mg administered orally as two experimental fixed dose combination tablets relative to the separate tablets. An open randomised three-way cross-over steady state trial in 6 female and 6 male healthy subjects

    Study Document Trial synopsis 1173.6_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.